Abundant evidences indicate that CCL17 can perform biological functions through interacting with CCR4 in a series of diseases, including tumor-promoting effects on hepatocellular carcinoma and bladder cancer [17-22]. The gene discussed is CCL17; the disease is urinary bladder carcinoma.